Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe psoriasis and atopic dermatitis, as they did not meet the primary endpoints.

Pharma stocks defy market trend: Dr Reddy’s, Aurobindo, Granules among top gainers as investors turn to defensive bets amid global developments (Image: Canva) Pharma stocks are bucking the ...

Shares of Indian pharmaceutical companies plunged close to 6% on Monday after US President Donald Trump proposed sweeping price cuts on prescription drugs and pharma prices in the US, although ...

Gland Pharma reported a 3 per cent decline in consolidated net profit. (Image: Pixabay) It’s a strong Monday across most of Dalal Street, but there are some definite pockets of concern.

For pharma, an industry in which gross margins are among the highest in the S&P 500, labor was never really the reason for moving offshore to places like Ireland—it was always about playing the ...

Appointed Utpal Singh as Chief Scientific Officer in April 2025 to lead the next wave of differentiated and innovative medicines, building on Zealand Pharma’s strong peptide heritage and its ...

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting pressure from the pharmaceutical industry concerned about potential ...

An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump administration disclosed Monday. The Department of Commerce initiated what’s ...

A recent study indicated journalists are engaging far more frequently on Bluesky than they do on X. When it comes to Big Pharma, the likes of Novartis, Bristol Myers Squibb and AstraZeneca have ...

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S ...

While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a momentary reprieve, renewed threats of drug duties—which have ...